Skip to content

Serum or Plasma Free Light Chain Immunoassay (Quantitative)

Published: August 9, 2026Updated: August 16, 2026

This test measures the levels of free light chains (kappa or lambda) in your blood, which can help diagnose conditions affecting plasma cells, such as multiple myeloma or other monoclonal gammopathies.

Quick summary

["Light chains help identify abnormal protein production in your blood."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
106608-3
Short code
S pyo DNA Fld Ql NAA+n-prb
Synonyms
S pyo DNA Fld Ql NAA+n-prb
Category
coagulation
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
non-probe-amp-tar
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why Is This Test Done?

Your healthcare provider may order this test if you have symptoms like unexplained fatigue, frequent infections, bone pain, or kidney problems. It’s also used to monitor conditions like multiple myeloma, lymphoma, or other blood disorders that involve abnormal protein production in plasma cells.

What to Expect Before the Test

No special preparation is needed. You may have a small needle inserted into your arm or vein to draw blood. If you’re on blood thinners, let your provider know before the test.

What the Test Results Mean

High levels of free light chains may indicate conditions like multiple myeloma, where plasma cells produce too many abnormal proteins. Low or normal levels are usually within expected ranges, but results depend on your medical history and symptoms.

Common Conditions Monitored

This test helps diagnose and monitor conditions such as multiple myeloma, Waldenström macroglobulinemia, and other monoclonal gammopathies. It may also be used in patients with kidney disease or unexplained anemia.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Free light chains are small protein fragments produced by plasma cells. When plasma cells become abnormal (e.g., in multiple myeloma), they may overproduce these light chains, which can accumulate in the blood and affect organs like the kidneys. Elevated levels can signal disease activity and guide treatment decisions.

Short name

Free Light Chain Test

Frequently asked questions

What causes abnormal light chain levels?
Abnormal light chain levels are most commonly linked to plasma cell disorders like multiple myeloma, where plasma cells become cancerous and produce excessive light chains. Other conditions, such as certain lymphomas or kidney diseases, may also cause changes in these levels.
Will I need to avoid certain foods or medications before the test?
No specific diet or medications are required. However, if you’re on blood thinners (e.g., warfarin), let your healthcare provider know before the blood draw to avoid excessive bleeding.
How long will it take to get my results?
Results are typically available within 1–3 business days, depending on your lab. Your provider will discuss them with you during your follow-up visit.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy